<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002204'>Pulmonary embolism</z:hpo> (PE) is a rare but life-threatening condition, which needs emergent treatment in children </plain></SENT>
<SENT sid="1" pm="."><plain>Though anticoagulation is the standard treatment for PE, recent studies revealed intrapulmonary thrombolytic therapy may produce more rapid clot lysis and less systemic complications in adult patients </plain></SENT>
<SENT sid="2" pm="."><plain>We reported a 10-year-old girl who had diffused multiple <z:e sem="disease" ids="C0034065" disease_type="Disease or Syndrome" abbrv="">pulmonary emboli</z:e> due to <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:e sem="disease" ids="C0087086" disease_type="Disease or Syndrome" abbrv="">thrombi</z:e> persisted in spite of intravenous <z:chebi fb="5" ids="28304">heparin</z:chebi> infusion for 3 days, which resolved quickly after intrapulmonary streptokinase infusion for 12 hours </plain></SENT>
</text></document>